Solvay
Short position disclosed on August 6, 2026.
2.07% of the capital sold short
3 disclosing funds
5 disclosures on record
BE0003470755 ISIN code
Funds holding Solvay Titelia
Evolution of the disclosed total
0%1%2%3%
May 2026Jun 2026Jul 2026Aug 2026
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Gladstone Capital Management LLP | 0.70% | new | July 1, 2026 | |
| Davidson Kempner European Partners, LLP | 0.69% | unchanged | April 13, 2026 | |
| Citadel Advisors Europe Limited | 0.68% | new | August 6, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 6, 2026 | Citadel Advisors Europe Limited | 0.68% | still open |
| August 5, 2026 | Citadel Advisors Europe Limited | 0.70% | still open |
| July 29, 2026 | Citadel Advisors Europe Limited | 0.60% | still open |
| July 1, 2026 | Gladstone Capital Management LLP | 0.70% | still open |
| April 13, 2026 | Davidson Kempner European Partners, LLP | 0.69% | still open |
Other companies sold short in Belgium
- Biocartis 1.21% of the capital sold short
- Barco 1.02% of the capital sold short
- CP Invest 0.98% of the capital sold short
- D'Ieteren Group 0.89% of the capital sold short
- Syensqo 0.89% of the capital sold short
- EVS 0.80% of the capital sold short
- Azelis 0.71% of the capital sold short
- Umicore 0.70% of the capital sold short
- Lotus Bakeries 0.69% of the capital sold short
- Sequana Medical 0.69% of the capital sold short
- WDP 0.51% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Solvay, source FSMA, data as at August 6, 2026, https://www.quivad.com/action/solvay